Ligand profile
LTP
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_32224 — DNA polymerase IV
Identifiers
Database identifiers and provenance.
- Ligand ID
LTP- PDB
4qwc- UniProt (similar protein)
Q97W02- Target protein
- KP13_32224
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 203.7
- −1 ≤ LogP ≤ 5 -1.30
- MW ≤ 500 Da 387.2
- LogP ≤ 5 -1.30
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 10
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 203.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C1[C@H]([C@@H](O[C@@H]1N2C=CC(=NC2=O)N)COP(=O)(O)OP(=O)(O)O)OC1[C@H]([C@@H](O[C@@H]1N2C=CC(=NC2=O)N)COP(=O)(O)OP(=O)(O)O)O
InChI=1S/C9H15N3O10P2/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(21-8)4-20-24(18,19)22-23(15,16)17/h1-2,5-6,8,13H,3-4H2,(H,18,19)(H2,10,11,14)(H2,15,16,17)/t5-,6+,8+/m1/s1InChI=1S/C9H15N3O10P2/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(21-8)4-20-24(18,19)22-23(15,16)17/h1-2,5-6,8,13H,3-4H2,(H,18,19)(H2,10,11,14)(H2,15,16,17)/t5-,6+,8+/m1/s1
FTDHDKPUHBLBTL-CHKWXVPMSA-NFTDHDKPUHBLBTL-CHKWXVPMSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00817
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand LTP →
- PDB RCSB structure 4qwc →
- UniProt UniProt Q97W02 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “LTP”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_32224.
PDB 31
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 3
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).